Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

448 results
  1. ... Kawata S, Tamura S, et al. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka hepatocellular carcinoma prevention study group. Ann Intern Med. 1998;129(2): ...
  2. NLM Digital Collections - AIDS bibliography, 1986-1987 
    Publication: [Bethesda, Md.] : Reference Section, Public Services Division, National Library of Medicine, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1987
    ... Antineoplastic Agents, Combined- THERAPEUTIC USE/ Clinical Trials/ Human/ Interferon Type I-ADVERSE EFFECTS- ♦THERAPEUTIC USE/ Opportunistic Infections-PREVENTION & CONTROL/ Recombinant Proteins-ADVERSE EFFECTS-THERAPEUTIC USE/ Sarcoma, ...
  3. ... PubMed : 21653306 ] Perrillo R: Benefits and risks of interferon therapy for hepatitis B. Hepatology 49 (5 Suppl): S103-11, 2009. [ PubMed : 19399806 ] Lai CL, Yuen MF: Prevention of hepatitis B virus-related hepatocellular carcinoma with ...
  4. ... exp Hepatitis B/dt, pc, th [Drug Therapy, Prevention & Control, Therapy] Hepatitis B virus/de [Drug Effects] (“hepatitis b” or hbv).ti,ab,kf. (interferon or “alfa 2a” or “alfa 2b” or entecavir ...
  5. ... Conway, B. N<10 25143025 Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial ...
  6. NLM Digital Collections - Chronic hepatitis C virus infection : developing direct-acting antiviral drugs for treatment 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
    ... K Seki, and Y Matsuzawa, 1998, Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients With Chronic Hepatitis C, Osaka Hepatocellular Carcinoma Prevention Study Group, Ann Intern Med, 129(2):94– ...
  7. ... test (TST) using the Mantoux method or commercial interferon-gamma release assays (IGRAs) or (2) treatment of LTBI with pharmacotherapy regimens that are currently recommended by the Centers for Disease Control and Prevention. We excluded studies of close contacts of persons ...
  8. ... been gathered to date, however, to establish that interferon is a safe and effective product for the treatment or prevention of disease dn man and, thus, its use ...
  9. ... resolve the associated heightened inflammatory response, including colitis. Prevention of primary manifestations: Lifelong daily antibacterial and antifungal prophylaxis is recommended; immunomodulatory therapy with interferon gamma (IFN-gamma) is part of the prophylactic ...
  10. NLM Digital Collections - The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the ... 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
    ... Hepatitis C Infection The primary goal of HCV treatment is the prevention of cirrhosis and hepatocellular carcinoma. The combination of pegylated interferon plus ribavirin (commonly referred to as “PR”) has ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last